12-31-2020
JPY per share | |
Price | 3,535.00 |
Dividend | 25.10 |
Earnings | 77.02 |
Cash-flow | 101.00 |
Book value | 666.98 |
Equity | 658.29 |
Daiichi Sankyo is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Daiichi Sankyo is a company from Japan, and his stocks are publicly traded.
Daiichi Sankyo paid a total dividend of 48,794 million JPY last year, for a market value of 6,872,040 millions (Market Cap 6,732,554 millions). Dividend per share of Daiichi Sankyo is 25.10 JPY, and his stock market price 3,535.00 JPY.
According to the chart below, where dividend yield is displayed, Daiichi Sankyo has a dividend yield of 0.71%, lower than the amount offered by both the market average and companies from Japan. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...
In addition, you should compare Daiichi Sankyo dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Japan.
About the ability of Daiichi Sankyo to maintain his current dividend of JPY 25.10 per share, an amount that accounts for 0.71%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Daiichi Sankyo payout on ernings is currently 32.59%, which is lower than the market average, but higher than companies of Health Care industry, which are 38.46% and 32.17% respectively. Both figures show that Daiichi Sankyo is in a good position to keep maintaining his dividend.
The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Daiichi Sankyo is JPY 101.00 per share, which is higher than the dividend per share paid by the company of JPY 25.10, so the company generates enough cash to maintain his dividend in the future.
The following figure shows payout ratios over earnings and cashflow of Daiichi Sankyo, compared againt world market average, Japan companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.
Finally, last moth Daiichi Sankyo showed a return of -4.30% compared to a worldwide 3.99% average, and a 3.09% of Health Care firms. Over the last year, the company obtained a 46.70% versus a worldwide performance of a 6.44%. More detailed information can be seen in the following graph for Japan and Pharmaceuticals and Biotechnology firms.
Daiichikosho. Japan. Consumer Goods.
Daikin Industries. Japan. Industrials.
Daimler AG. Germany. Consumer Goods.
Dairy Farm International Holdings. Hong-Kong. Consumer Services.
Daito Trust Constr. Japan. Financials.
Daiwa House Industry. Japan. Consumer Goods.
Daifuku. Japan. Industrials.
Daido Steel Co. Japan. Basic Materials.
Daicel. Japan. Basic Materials.
Dai Nippon Printing. Japan. Consumer Services.
Dai-ichi Life Insura. Japan. Financials.
Dah Sing Banking Gro. Hong-Kong. Financials.
All rights reserved
information advertisement legal
Part of Enciclopedia Financiera Group
Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.